NCT02235493View on ClinicalTrials.gov

Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
HypophosphatasiaBone Disease
Interventions
BIOLOGICAL

Retrospective Case Only

Trial Locations (1)

Unknown

St Louis

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY

NCT02235493 - Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09 | Biotech Hunter | Biotech Hunter